Kwak, Soyoung
Lim, Ji Sun
Kim, Shin
Kwon, Ye Jin
Yu, Mi-Hee
Park, Mee-Na
Choi, Dong Kyu
Hong, Jeong-Ho
Kim, Hae Won
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00243836)
National Research Foundation of Korea (RS-2023-00243836)
National Research Foundation of Korea (RS-2024-00439078)
National Research Foundation of Korea (RS-2023-00243836)
National Research Foundation of Korea (RS-2023-00243836)
National Research Foundation of Korea (RS-2023-00243836)
Chong Kun Dang Pharmaceutical Corp
national research foundation of korea (RS-2024-00405401)
Article History
Received: 14 May 2025
Accepted: 19 December 2025
First Online: 30 December 2025
Declarations
:
: The authors declare no competing interests.
: All animal experiments were performed in accordance with the guidelines on the use of animals and humans in neuroscience research as revised and approved by the Keimyung University. Ethical approval is obtained from animal ethics committee of the Keimyung University (Daegu, South of Korea, Approval Number KM-2023-15).
: The study is reported following the recommendations of the ARRIVE guidelines.